A quantitative trait locus on chromosome 22 for serum leptin levels adjusted for serum testosterone

Obesity Research

Volumn 10, Issue 7, 2002, Pages 602-607

  Martin, Lisa J ^a,b   Mahaney, Michael C ^b   Almasy, Laura ^b   Hixson, James E ^c   Cole, Shelley A ^b   MacCluer, Jean W ^b   Jaquish, Cashell E ^d   Blangero, John ^b   Comuzzie, Anthony G ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Obesity; Sex hormones; Variance component linkage analysis

Indexed keywords

LEPTIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD; CHROMOSOME 22; ETHNOLOGY; FEMALE; GENETIC LINKAGE; GENETICS; GENOTYPE; HISPANIC; HUMAN; MALE; MEXICO; MIDDLE AGED; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; SEXUAL DEVELOPMENT;

ADULT; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENOTYPE; HISPANIC AMERICANS; HUMANS; LEPTIN; LOD SCORE; MALE; MEXICO; MIDDLE AGED; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0036632277     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.82     Document Type: Article

References (34)

1. Zhang Y, Proenca R, Barone M, Leopold L, Freidman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
2. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
3. Haffner SM, Gingerich RL, Miettinen H, Stern MP. Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord. 1996;20:904-8.
4. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1995;1: 1155-61.
5. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 1996;81:3909-13.
6. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81:3424-7.
7. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nature Genet. 1997;15: 273-6.
8. Saad MF, Damani S, Gingerich RL, et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab. 1997;82:579-84.
9. Martin LJ, Mahaney MC, Almasy L, et al. The sexual dimorphism in serum leptin levels is a result of genotype by sex interactions. Obes Res. 2002;10:14-21.
10. Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya G, Garry PJ. Age-related changes in sex hormones affect the sex difference in serum leptin levels independently of changes in body fat. Metabolism. 1999;48:378-84.
11. Mitchell BD, Kammerer CM, Blangero J, et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans - the San Antonio Family Heart Study. Circulation. 1996;94:2159-70.
12. Ma ZM, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem. 1996;42:942-6.
13. Green P, Falls K, Crooks S. Documentation for CRI-MAP, version 2.4. St. Louis, MO: Department of Genetics, Washington University School of Medicine; 1990.
14. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54: 535-43.
15. Almasy L, Blangero J. Multipoint quantitative trait-linkage analysis in general pedigrees. Am J Hum Genet. 1998;62: 1198-211.
16. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol. 1997;14:959-64.
17. Hopper JL, Matthews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet. 1982;46: 373-83.
18. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet. 1999;65:531-44.
19. Goldgar DE. Multipoint analysis of human quantitative genetic variation. Am J Hum Genet. 1990;47:957-67.
20. Fulker DW, Cherny SS, Cardon LR. Multipoint interval mapping of quantitative trait loci, using sib pairs. Am J Hum Genet. 1995;56:1224-33.
21. Goring HH, Terwilliger JD, Blangero J. Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet. 2001;69:1357-69.
22. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-7.
23. Elbers JM, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJ. Reversal of the sex differences in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab. 1997;82: 3267-70.
24. Dunham I, Shimizu N, Roe BA, et al. The DNA sequence of human chromosome 22. Nature. 1999;402:489-95.
25. Sher T, Yi HF, McBride OW, Gonzalez FJ. CDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 1993;32:5598-5604.
26. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645-50.
27. Gottlicher M, Widmark E, Li Q, Gustafsson JA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. PNAS. 1992;89:4653-7.
28. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. PNAS. 1993;90:2160-4.
29. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999; 103:1489-98.
30. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes. 2001;50:411-7.
31. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem. 1998;273:29577-85.
32. Budarf M, McDonald T, Sellinger B, Kozak C, Graham C, Wistow G. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics. 1997;39:235-6.
33. Hirokawa J, Sakaue S, Furuya Y, et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem. 1998;123: 733-9.
34. Benigni F, Atsumi T, Calandra T, et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest. 2000; 106:1291-300.